(Latest Update)
Diagnosis & Management in
Psychiatric-Mental Health II
Practicum | Questions & Verified
Answers | 100% Correct | Grade A -
Chamberlain
Question:
The most common adverse effect associated with SSRI and SNRI
Answer:
neonatal withdrawal syndrome
impacts up to 30% of babies born to mothers who take antidepressants
Question:
SSRI withdrawal symptoms in newborns with maternal exposure
Answer:
neonatal withdrawal syndrome
,Question:
SSRI withdrawal symptoms in newborns with maternal exposure
Answer:
neonatal withdrawal syndrome
-Symptoms: tremors, high-pitched crying, disturbed sleep
--peaks between 2-4 days after birth
-No evidence that discontinuing/tapering dosages in the last trimester
reduces risk to the infant
--Paroxetine may increase risk of atrial septal defects!! *
Question:
Depression symptoms in pregnancy
Answer:
Low mood
Fatigue
Anxiety
Negative thoughts
Feelings of guilt
Avoiding people
Lack of focus
,Question:
Risk factors for maternal mental health disorders
Answer:
Smoking
Lack of social support
Poor relationship quality
Pregnancy complications
Personal or family history of depression
History of physical or sexual abuse
Unintended pregnancy
Life stress
Chronic physical conditions
Prior pregnancy with fetal/infant loss
History of mental illness
Question:
most used substance in the perinatal period
Answer:
tobacco, followed by alcohol, cannabis, and other illicit drugs
, Question:
ETOH in preg
Answer:
-Exposure within the 1st trimester correlates with the most significant
alcohol-related birth outcomes.
--increased risk for miscarriage, stillbirth, congenital anomalies, low birth
weight, small for gestational age, and preterm delivery
-Lifelong effects of alcohol use disorder on children:
--fetal alcohol spectrum disorders (FASDs), neurodevelopmental and central
nervous system deficits, speech and language challenges, cognitive and
behavioral deficits, impaired executive functioning, and psychosocial
difficulties in adulthood
Question:
OUD tx in preg
Answer:
-Methadone and buprenorphine-the most prescribed MAT for OUD in
pregnancy.
-Dosing may be increased during the 2nd/3rd trimesters d/t increased blood
volume/ metabolism.
-Naltrexone- NOT usually recommended
-Clients who initiate treatment during pregnancy/ become pregnant while
using MAT should continue treatment through pregnancy and the
postpartum period.